2022 ´ëÇѳëÀοä¾çºñ´¢ÀÇÇÐȸ Á¦1Â÷ ÇмúÁý´ãȸ : 2022-03-19±³À°ÀÏÀÚ : 2022-03-19
±³À°Àå¼Ò : Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
2022 ´ëÇѳëÀοä¾çºñ´¢ÀÇÇÐȸ Á¦1Â÷ ÇмúÁý´ãȸÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѳëÀοä¾çºñ´¢ÀÇÇÐȸ
´ã´çÀÚ : ¿¡ÀÌÇ÷¯½º
¿¬¶ôó : 02-582-8572
À̸ÞÀÏ :
app@app2010.com ±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀοø : 99¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
°æ»óºÏµµ±³À°½Ã°£ : 4 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í 1. ¼±Âø¼ø 99ÀÎ ÀÌÇÏ Á¢¼ö(»çÀüµî·Ï¸¸ °¡´É) 2. ÇöÀåµî·Ï ¾øÀ½
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 09:30~09:50 µî·Ï ()
±âŸ 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 09:50~10:00 °³È¸»ç ()
±³À°½Ã°£ 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 10:00~10:20 1. Sexual hormone and lower urinary tract dysfunction in aging? Á¤Çöö(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 10:20~10:40 2. Hormone and nocturia À°Çüµ¿(¼¿ïÀÇ´ë)
±³À°½Ã°£ 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 10:40~11:00 3. LUTS associated with dopamine and serotonin in aging? Á¶¿µ»ï(¼º±Õ°üÀÇ´ë)
Åä·Ð 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 11:00~11:20 Panel discussion ()
±³À°½Ã°£ 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 11:20~11:40 1. Strategy for asymptomatic persistent pyuria in Geriatrics ¾çÈñÁ¶(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 11:40~12:00 2. What is the appropriate catheter exchange cycle in the elderly who need long-term catheterization? °íµ¿ÈÆ(°Ç¾çÀÇ´ë)
±³À°½Ã°£ 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 12:00~12:20 3. Clinical features and management of pyuria in patients with long-term catheter indwelling. ¹è»ó¶ô(°¡Å縯ÀÇ´ë)
Åä·Ð 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 12:20~12:40 Panel discussion ()
½Ä»ç 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 12:40~13:30 Á¡½É½Ä»ç ()
±³À°½Ã°£ 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 13:30~13:45 1. LUTS in sarcopenic elderly ±è¼öÁø(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 13:45~14:00 2. Erectile dysfunctions in sarcopenic elderly ±èµ¿¼ö(°æÈñÀÇ´ë)
±³À°½Ã°£ 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 14:00~14:15 3. Urologic Cancer in sarcopenic elderly ÀÓ¹üÁø(¿ï»êÀÇ´ë)
Åä·Ð 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 14:15~14:30 Panel discussion ()
ÈÞ½Ä 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 14:30~14:50 Coffee Break ()
±³À°½Ã°£ 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 14:50~15:05 1. How is terazosin different from other Alpha Blockers? ±ÇÈÖ¾È(ÇѾçÀÇ´ë)
±³À°½Ã°£ 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 15:05~15:20 2. What makes doxazosin different from other Alpha Blockers? ±èÁؼ®(±¤Áֱ⵶º´¿ø)
±³À°½Ã°£ 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 15:20~15:35 3. Is alfuzosin different from other Alpha Blockers? ±è¿õºó(¼øõÇâÀÇ´ë)
Åä·Ð 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 15:35~15:50 Panel discussion ()
±âŸ 03-19 Æ÷Ç×¼¼¸í±âµ¶º´¿ø 10Ãþ ´ë°´ç 15:50~01:00 Æóȸ»ç ()